Opinion|Videos|May 22, 2024
The Patient Experience: From Symptoms to Diagnosis of Alzheimer Disease
The expert panel offers comprehensive insights on the patient journey for people with Alzheimer disease, highlighting symptoms, challenges, and the diagnostic process.
Advertisement
Episodes in this series
- [Dr Nair] Please describe the current patient journey for a patient with AD.Walk us through how and to which provider a patient may initially present and then how long before a patient receives a diagnosis.
Advertisement
Related to this article
Antimicrobial resistance in bronchiectasis and cystic fibrosis varied widely in a study spanning 11 centers on 3 continents.
Experts break down the GOLD 2026 COPD guidelines, highlighting updates to diagnosis criteria, Group E risk categories, and nonpharmacologic interventions.
An economic evaluation found nontargeted hepatitis C screening in emergency departments offered the greatest health benefit at a cost-effective price.
Naim Alkhouri, MD, on when to judge MASH treatment response, counseling on weight and muscle loss, primary care screening, and future trial end points.
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Invivyd presented preclinical IDWeek 2026 data on VMS063, an investigational antibody that neutralized B3 and D8 measles variants in vitro.
Sphingolipid profiles in plasma and breath condensate differed between IPF and f-HP and tracked with disease severity, CHEST 2026 data show.
The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).
Advertisement
Advertisement
Trending on AJMC
1
NYC Marathon Death Puts Rhabdomyolysis Risk Factors in Focus
2
Acoramidis Linked to Fewer Hospitalizations Than Tafamidis in ATTR-CM
3
Real-World Evidence, Rare Liver Disease Data Headline Kidney Week 2026
4
EEOC Reportedly Plans to Narrow Pregnancy Accommodation Rules
5